SUBSCRIBE

Breaking News on Supplements & Nutrition - North AmericaEU edition

Report abuse about a comment

Further comment on dubious study

As I stated a week ago in response to the recently released study on resveratrol, the fault here is with the study design and protocol itself, not the resveratrol used in the study. The dosage used in this study was ridiculously low, compared to all earlier studies. In the case of the successful Albert Einstein Medical School study and the more recent Florida Pharmacology School study the dosages were approximately 10 to 20 times this amount. This dosage is consistent with the supplements used in those trials, specifically biotivia transmax and bioforte, which are readily available without a prescription. Using a dosage of only 75mg was tantamount to giving a heart attack victim one aspirin.

In all previous studies on actual type 2 diabetic patients or those suffering impaired glucose tolerance, a sign of impending diabetes, resveratrol was extremely effective in improving glucose tolerance, enhancing metabolic function and blocking the onset of diabetes.

As a cell biologist who has been involved in several human clinical trials of transmax and bioforte resveratrol against diabetes, I can only imagine that this study was designed by a pharmaceutical company to fail intentionally. The pharmas are clearly aware of the potential of resveratrol to cut into their sales of Metformin, a multi-billion dollar earner for the drug companies, and are on a campaign to discredit the compound.

As a researcher I question why the clinicians in this study would select as subjects women who have no issues with glucose tolerance, who were non-obese, and who did not exhibit signs of diabetes. This is equivalent to testing a compound designed to treat cancer on a group of subjects none of whom has cancer. Again, we see a troubling signal of possible pharma involvement.

Posted by James Betz
01 November 2012 | 08h40

Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.

Your name *
Your email *

We will not publish your email on the site

Reason *

Back to: Resveratrol study results don’t tell the whole story on benefits: Expert

Spotlight

Post election committee shuffles emphasize need for industry engagement, observers say

Post election committee shuffles emphasize need for industry engagement, observers say

The landslide victory of Republican House and Senate candidates in the recent midterm elections will have broad...

‘Critical that CFSAN has a scientist at the helm’: Industry welcomes new center leader

‘Critical that CFSAN has a scientist at the helm’: Industry welcomes new center leader

Dr Susan Mayne will replace Michael Landa at the FDA’s Center for Food Safety and Applied Nutrition,...

There's room for growth in supply of omega-3 oils from US sources, GOED official says

There's room for growth in supply of omega-3 oils from US sources, GOED official says

The recent closure of the fishing season in Peru will sent a pulse through the omega-3s market....

Optimal selenium status linked to better mood for young adults: Study

Optimal selenium status linked to better mood for young adults: Study

Maintaining optimal levels of selenium may improve mood and be associated with lower risk of depressive symptoms...

DSHEA at 20, changes on Capitol Hill, and the potential of technology: CRN’s Conference as it happened

DSHEA at 20, changes on Capitol Hill, and the potential of technology: CRN’s Conference as it happened

The Council for Responsible Nutrition's Annual Meeting and Conference was held in Dana Point, CA, with marquee...

Tech innovation in health care delivery will transform debate now dominated by struggle over "Obamacare"

Tech innovation in health care delivery will transform debate now dominated by struggle over "Obamacare"

A dizzying array of personalized digital health care solutions may in the future help the Affordable Care...

Negative media and a lack of innovation: Vitamin Shoppe CEO on ’positive’ but ‘lower than expected’ Q3 results

Negative media and a lack of innovation: Vitamin Shoppe CEO on ’positive’ but ‘lower than expected’ Q3 results

Supplement retailing giant Vitamin Shoppe has reported a 3.1% increase in comparable retail store sales and a...

Citing Cohen's research, agency removes DMBA-containing products from military shelves

Citing Cohen's research, agency removes DMBA-containing products from military shelves

A number of dietary supplements in the sports nutrition category that contain the stimulant ingredient DMBA have...

Flavonoids may be ‘important to promoting broad health and wellbeing in aging’: Harvard study

Flavonoids may be ‘important to promoting broad health and wellbeing in aging’: Harvard study

Higher intakes of flavonoid compounds in the diet during middle age may boost healthy aging in women,...

GNC CEO: ‘We're going to be offering far more plant-based and nature-based proteins in our store’

GNC CEO: ‘We're going to be offering far more plant-based and nature-based proteins in our store’

Supplements retailing giant GNC is undertaking a ‘reset’ with an increased focus on natural, organic and vegan-vegetarian...